ABUS Arbutus Biopharma Corporation logo

ABUS Arbutus Biopharma Corporation

Healthcare
$4.35-2.03%ClosedMarket Cap: $859.3M

As of 2026-05-25

Analyst Consensus

Consensus

Buy

Target (Consensus)

$8.50

Target (Median)

$8.50

Target Range

$8.50 - $8.50

Upside from current price: 95.4%

Rating Distribution

1 Strong Buy2 Buy0 Hold0 Sell0 Strong Sell
Recent Analyst Ratings
DateFirmActionRatingPrevious
2025-11-14Chardan CapitalmaintainBuyBuy
2025-08-11Chardan CapitalmaintainBuyBuy
Forward Estimates
PeriodEPS Est.Revenue Est.# Analysts
Thu Dec 31$0.30$91.1M1
Fri Dec 31$-0.09$2.7M1
Sun Dec 31$-0.14$55.9M1
Mon Dec 31$0.34$173.5M1